Latest equities thinking
-
Issuance, support from equities and volatility: The outlook for convertible bonds in 2021
18 Dec 2020
Shawn Mato, convertible bond fund manager, picks three themes that could have a big say in how the asset class performs in 2021.
-
Recovery, divergence and externalities: The outlook for global equities in 2021
15 Dec 2020
Giles Parkinson, global equities portfolio manager at Aviva Investors, looks at three themes that will shape the asset class in 2021.
-
Reversal of fortunes, Brexit and dividends: The outlook for UK equities in 2021
11 Dec 2020
Trevor Green, UK equity portfolio manager at Aviva Investors, picks three themes that could have a big say in how the asset class performs in 2021.
-
Selectivity, sanctions and decarbonisation: The outlook for emerging market equities in 2021
11 Dec 2020
Alistair Way, head of emerging market equities at Aviva Investors, looks at three themes that will shape the asset class in 2021.
-
COVID, climate and Black Lives Matter: The stories that defined 2020
10 Dec 2020
We select some of our key pieces of content in a year of unending drama.
-
Chemical compounds: The good, the bad and the ugly
9 Dec 2020
After decades of secrecy, light is increasingly being shone on the potentially hazardous compounds produced by chemical companies. In the latest instalment of our editorial series, Link, experts from Aviva Investors’ credit, equities and ESG teams discuss the prevalence of chemicals in modern life, and how to balance usefulness and safety.
-
Pricing power is the magic ingredient for equity investors
27 Nov 2020
Evidence that a company wields pricing power in its industry is the best indication of a sustainable competitive advantage, argues Giles Parkinson.
-
Once bitten, twice shy: Is there value in tech by avoiding the FAANGs?
30 Oct 2020
The gravity-defying rally in technology shares has led some commentators to draw comparisons with the dot.com bubble of the late 1990s. However, Mikhail Zverev and Alistair Way believe there are still opportunities to be found in some of the sector’s less-fashionable stocks.
-
US Election 2020: Expect the unexpected
29 Oct 2020
As the US presidential election looms, we explore potential scenarios – from a Democratic “blue sweep” to a Trump re-election to a divided government – and assess the implications for investors.
-
Turn and face the change: How to invest dynamically in an uncertain world
21 Oct 2020
Equity markets are slow to price in the implications of change. This creates opportunities for dynamic, style-agnostic investors to take advantage, argue Caroline Galligan and David Cumming.
-
Don’t feed the troll: Social media companies face reckoning over hate speech
28 Sep 2020
Facebook, Twitter and other platforms are drawing criticism for their failure to tackle hate content. But will the hit to their reputation do any lasting commercial damage?
-
Investing in the gut: Fixing the bacterial bugs in our microbiome
21 Sep 2020
COVID-19 has intensified interest in the human microbiome, as researchers contemplate whether bacteria living in the gut might affect susceptibility to infection. Drawing on our experience in public markets and Ahren Innovation Capital’s knowledge of private markets, we look at the companies making strides in live biotherapeutics, using ‘bugs as drugs’, and key challenges that need to be overcome.
Subscribe to AIQ
Receive our award-winning insight on key investment themes, direct to your inbox.
Important information
This site is intended for U.S. Institutional Investors only. If you are not a U.S. Institutional Investor, please visit the global Aviva Investors homepage.
The content on this site and any posts on Aviva’s other social media or third party platforms is provided for informational and educational purposes (“Online Content”) only, and nothing herein constitutes investment, legal, accounting or tax advice. The Online Content is general in nature, not directed to any category of investors and should not be regarded as individualized, a recommendation, investment advice or a suggestion to engage in or refrain from any investment-related course of action. Investment decisions and the appropriateness of this material should be made based on an investor's individual objectives and circumstances and in consultation with their advisors. Views expressed in “posts” (including podcasts, videos, blogs and social media) by Aviva’s personnel are not necessarily the views of Aviva or its respective affiliates.
Information, examples and any charts shown in the Online Content are for information purposes only current as of the date of this material and is subject to change without notice. Information is obtained from third party sources deemed reliable, but there is no representation or warranty as to its accuracy, completeness or reliability. In addition, posts may include third-party advertisements; Aviva has not reviewed such advertisements and does not endorse any advertising content contained therein.
This material shown in the Online Content may include estimates, outlooks, projections and other “forward-looking statements.” Past performance does not predict future returns. There can be no assurances that the investment objectives will be achieved or investment strategies will be successful. Investments in fixed income entails risk. Due to a variety of factors, actual events or market behavior may differ significantly from any views expressed. Indexes are unmanaged and are not available for direct investment. Past performance is no guarantee of future results.
Aviva Investors Americas LLC is an investment adviser registered with the U.S. Securities and Exchange Commission. Registration as an investment adviser does not imply any special skill or training. Aviva products and services may not be available in all jurisdictions or to all client types.
Except as otherwise authorized, this information may not be shown, copied, transmitted, or otherwise given to any third party without Aviva's prior written consent.